Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Phase 3 Study of Oral Ibrexafungerp (SCY-078) Vs. Placebo in Subjects With Recurrent Vulvovaginal Candidiasis (VVC)

ClinicalTrials.gov ID: NCT04029116

Public ClinicalTrials.gov record NCT04029116. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 1:53 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Ibrexafungerp (SCY-078) Compared to Placebo in Subjects With Recurrent Vulvovaginal Candidiasis (VVC)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of oral ibrexafungerp (formerly "SCY-078") compared to placebo in female subjects 12 years and older with recurrent VVC (RVVC).

Study identification

NCT ID
NCT04029116
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Scynexis, Inc.
Industry
Enrollment
440 participants

Conditions and interventions

Eligibility (public fields only)

Age range
12 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 21, 2019 (Actual)
Primary completion
Sep 1, 2021 (Actual)
Completion
Nov 29, 2021 (Actual)
Last update posted
Jun 18, 2023

2019 – 2021

United States locations

U.S. sites
25
U.S. states
14
U.S. cities
22
Facility City State ZIP Site status
Precision Trials LLC Phoenix Arizona 85032 —
Women's Healthcare Research Corp San Diego California 92111 —
Altus Research - Hunt - PPDS Lake Worth Florida 33461 —
New Age Medical Research Corporation Miami Florida 33186 —
Healthcare Clinical Data Inc North Miami Florida 33161 —
Clinical Research Prime - ClinEdge - PPDS Idaho Falls Idaho 83404 —
Clinical Trials Management Covington Louisiana 70433 —
Women Under Study, LLC New Orleans Louisiana 70125 —
Unified Women's Clinical Research Hagerstown Maryland 21740 —
Wayne State University Detroit Michigan 48201 —
Center For Women's Health and Wellness LLC Lawrenceville New Jersey 08648 —
Lawrence Obstetrics Gynecology Clinical Research LLC Lawrenceville New Jersey 08648 —
Bosque Women's Care Albuquerque New Mexico 87109 —
Carolina Women's Research and Wellness Center Durham North Carolina 27713 —
Unified Womens CLinical Research Greensboro North Carolina 27408 —
Unified Women's Clinical Research Raleigh Raleigh North Carolina 27607 —
M3 Wake Research, Inc Raleigh North Carolina 27612 —
Group For Women Winston-Salem North Carolina 27103 —
Lyndhurst Clinical Research Winston-Salem North Carolina 27103 —
Cleveland Clinic Cleveland Ohio 44195 —
Obstetrics and Gynecology Associates of Erie, PC Erie Pennsylvania 16507 —
Jefferson University Hospital Philadelphia Pennsylvania 19107 —
Chattanooga Medical Research Inc Chattanooga Tennessee 37404 —
Medical Research Center of Memphis, LLC Memphis Tennessee 38120 —
TMC Life Research Inc Houston Texas 77054 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04029116, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 18, 2023 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04029116 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →